Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of High-Dose Symbicort vs Terbutaline in Japanese Asthma Patients
NCT00837967Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2009
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide in asthma, sponsored by AstraZeneca. Started Jan 2009; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00837967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00837967.